BI
ABBV icon

Binnacle Investments’s AbbVie ABBV Stock Holding History

Binnacle Investments’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$163K Buy
706
+213
+43% +$43.4K 0.1% 87
2025
Q2 		$91.5K Buy
493
+123
+33% +$22.9K 0.06% 107
2025
Q1 		$77.5K Buy
+370
New +$71.9K 0.06% 107

Other funds holding ABBV

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Binnacle Investments's ABBV Position: Q3 2025 in Review

Binnacle Investments increased its AbbVie (ABBV) stake by 43% in Q3 2025, buying an estimated $43.4K and bringing the position to 706 shares worth $163K. The position accounts for 0.1% of the portfolio, ranked #87.

Binnacle Investments first reported a position in ABBV in Q1 2025 and has held it in 3 quarters since. 3,905 funds tracked by Wall St. Rank hold ABBV as of Q3 2025.

  • Binnacle Investments held 706 shares of AbbVie worth $163K as of Q3 2025.
  • Binnacle Investments bought 213 AbbVie shares in Q3 2025, an estimated $43.4K.
  • AbbVie made up 0.1% of Binnacle Investments's portfolio in Q3 2025, its #87 holding.
  • Binnacle Investments first reported a position in AbbVie in Q1 2025 and has held it in 3 quarters since.
  • 3,905 funds tracked by Wall St. Rank held AbbVie as of Q3 2025.

Based on Binnacle Investments's 13F filing for Q3 2025, filed 14 Nov 2025.